Annex Advisory Services LLC Has $1.22 Million Position in Balchem Co. (NASDAQ:BCPC)

Annex Advisory Services LLC lifted its position in Balchem Co. (NASDAQ:BCPC) by 35.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,496 shares of the basic materials company’s stock after acquiring an additional 1,959 shares during the period. Annex Advisory Services LLC’s holdings in Balchem were worth $1,222,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Heritage Family Offices LLP boosted its position in shares of Balchem by 8.3% during the fourth quarter. Heritage Family Offices LLP now owns 1,420 shares of the basic materials company’s stock worth $231,000 after purchasing an additional 109 shares in the last quarter. Argent Capital Management LLC lifted its holdings in Balchem by 39.1% during the fourth quarter. Argent Capital Management LLC now owns 5,821 shares of the basic materials company’s stock worth $949,000 after acquiring an additional 1,636 shares in the last quarter. Watts Gwilliam & Co. LLC grew its stake in Balchem by 63.7% in the fourth quarter. Watts Gwilliam & Co. LLC now owns 35,069 shares of the basic materials company’s stock valued at $5,438,000 after acquiring an additional 13,642 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of Balchem by 1.7% in the third quarter. JPMorgan Chase & Co. now owns 458,986 shares of the basic materials company’s stock worth $80,782,000 after acquiring an additional 7,721 shares in the last quarter. Finally, Independent Solutions Wealth Management LLC acquired a new stake in shares of Balchem during the third quarter worth about $203,000. Institutional investors own 87.91% of the company’s stock.

Wall Street Analysts Forecast Growth

BCPC has been the subject of a number of research reports. HC Wainwright increased their target price on Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. StockNews.com raised shares of Balchem from a “hold” rating to a “buy” rating in a research report on Monday, October 28th.

Balchem Trading Down 0.2 %

NASDAQ BCPC opened at $160.15 on Tuesday. The company has a market cap of $5.21 billion, a PE ratio of 43.05, a PEG ratio of 4.15 and a beta of 0.69. Balchem Co. has a 12 month low of $136.74 and a 12 month high of $186.03. The stock has a 50 day moving average of $170.18 and a 200-day moving average of $170.94. The company has a current ratio of 2.98, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21.

Balchem Increases Dividend

The firm also recently announced an annual dividend, which was paid on Friday, January 17th. Stockholders of record on Thursday, December 26th were issued a dividend of $0.87 per share. The ex-dividend date of this dividend was Thursday, December 26th. This is a boost from Balchem’s previous annual dividend of $0.79. This represents a dividend yield of 0.4%. Balchem’s dividend payout ratio (DPR) is currently 23.39%.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.